Lamivudine and Tenofovir Disoproxil

CIMDUO

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

NADAC/unit N/A

No Shortage Tier 1: 17.9%

Lamivudine and Tenofovir Disoproxil suppresses hepatitis B virus replication.

Covered Lives

Generic Manufacturers

MYLAN LABORATORIES LTD

Explore in the Ecosystem

rxsaver.aiCompare prices for Lamivudine and Tenofovir Disoproxil drfinder.aiFind doctors who prescribe Lamivudine and Tenofovir Disoproxil rxnews.aiLatest news about Lamivudine and Tenofovir Disoproxil

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.